Vaccine-Related Injuries: Why Canada Needs to Adopt a No-Fault Compensation Scheme in Light of the New H1N1 Vaccine by Fowler, Erin
Dalhousie Journal of Legal Studies 
Volume 19 InfraReads: DJLS Online Supplement Article 4 
6-1-2010 
Vaccine-Related Injuries: Why Canada Needs to Adopt a No-Fault 
Compensation Scheme in Light of the New H1N1 Vaccine 
Erin Fowler 
Follow this and additional works at: https://digitalcommons.schulichlaw.dal.ca/djls 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative 
Works 3.0 License. 
Recommended Citation 
Erin Fowler, "Vaccine-Related Injuries: Why Canada Needs to Adopt a No-Fault Compensation Scheme in 
Light of the New H1N1 Vaccine" (2010) 19:infraread Dal J Leg Stud 78. 
This Article is brought to you for free and open access by the Journals at Schulich Law Scholars. It has been 
accepted for inclusion in Dalhousie Journal of Legal Studies by an authorized editor of Schulich Law Scholars. For 
more information, please contact hannah.steeves@dal.ca. 
 InfraRead: DJLS Online Supplement Vol. 1 78 
VACCINE-RELATED INJURIES:  WHY CANADA NEEDS TO ADOPT A NO-FAULT 







On June 11, 2009, the World Health Organization (“WHO”) declared the H1N1 
influenza a pandemic.  H1N1 is a strain of the influenza virus that, in the past, usually 
only affected pigs.  In the spring of 2009, it emerged in people in North America.  This is 
a new strain of influenza, and because humans have little to no natural immunity to this 
virus, it can cause serious and widespread illness.1  As of November 1, 2009, there were 
more than 440 000 laboratory-confirmed worldwide cases of pandemic influenza H1N1 
and over 6000 deaths reported to WHO.2  In late October, the H1N1 vaccine was 
approved for rollout across Canada.  Since then, Canadians lined up en masse across the 
provinces and territories to receive the vaccine.  This was in part due to the strong 
urging by the Government of Canada for every Canadian to receive the vaccine.   
Despite the advantages of wide-scale immunization, there is a significant drawback – 
many people who receive vaccines each year suffer adverse effects.3  Despite this fact, 
Quebec is the only province in Canada that currently has a plan to compensate people 
who may be injured by vaccinations.  For the majority of Canadians, the only recourse 
when injured by a vaccine is to go through the tort system.   
 
By requiring individuals to proceed through the tort system (i.e.: having to prove 
someone was at fault for causing the injury), many people who have a severe reaction 
from a vaccine are left with no remedy.  This article urges more jurisdictions in Canada 
                                                 
* Erin Fowler, B.A. (McMaster), is a law student at Dalhousie University’s Schulich School of Law, and expects to graduate in 
May 2011.  Subsequent to this article being accepted for publication in InfraRead, Erin was appointed as one of three Editors-in-
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1 Public Health Agency of Canada, Frequently Asked Questions – H1N1 Flu Virus, online: Public Health Agency of Canada 
<http://www.phac-aspc.gc.ca/alert-alerte/h1n1/faq_rg_h1n1-eng.php>. 
2 World Health Organization, Pandemic H1N1 (2009) – Update 72, online: World Health Organization 
<http://www.who.int/csr/don/2009_10_30/en/index.html>. 
3 Nicole J. Kutlesa, “Creating a Sustainable Immunization System in Canada – The Case for a Vaccine-Related Injury 
Compensation Scheme” (2004) 12 Health L.J. at 201. 
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to adopt a no-fault compensation scheme for vaccine-related injuries.  It will explore 
how vaccine-related injuries are currently covered under medical malpractice and 
manufacturer liability schemes, and the reasons why many believe that medical 
malpractice approaches should be retained in their entirety.  In contrast to these beliefs, 
this article will address how a no-fault system would prove to be an adequate and 
efficient means of compensating individuals who have been injured by vaccines.  This 
argument will be advanced by looking at how other jurisdictions have implemented no-
fault compensation for vaccine-related injuries.  Finally, this article will address why it 
is essential for Canada to adopt this new compensation system as soon as possible in 
order to address the needs of citizens who may be injured by the new H1N1 vaccine.   
 
I. IMMUNIZATION IN CANADA 
 
The Public Health Agency of Canada describes immunization as an important, cost-
effective, and successful public health intervention.  Vaccination effectively prevents 
disease, improves the health of Canadians, and reduces pressures on the Canadian 
health care system.4  Although immunization recommendations are made at the 
national level, with the exception of two provinces, immunization is not mandatory in 
Canada.  This is in contrast to the United States, where almost all states require that 
children receive vaccination as a condition of attending school, and reprisals range from 
denying poor pregnant mothers the right to get food or welfare unless all their children 
are immunized, charges for child abuse for failure to have your child immunized, 
imprisonment of a teenager for failure to show proof of a second MMR (measles-
mumps-rubella) shot, and denying children the right to attend school.5  Although there 
is no explicit mandatory immunization scheme throughout most of Canada, the current 
immunization system in place creates enough pressure so as to have almost the effect of 
a mandatory scheme. 
 
                                                 
4 Public Health Agency of Canada, Immunization: The Most Successful Public Health Measure, online: Public Health Agency of 
Canada <http://www.phac-aspc.gc.ca/im/measure-intervention-eng.php>. 
5 Supra note 3 at 204. 
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In Canada, immunization is a shared responsibility between the federal, provincial, and 
territorial governments.6  Despite this arrangement, the large majority of costs are borne 
by the provinces and territories, as each province and territory is responsible for the 
structure and implementation of the system of immunization.7  The public health 
branch of each province determines which vaccines should be administered and to 
whom they should be administered.8  In planning their immunization programs, 
provinces and territories adjust their recommended schedules and selection of vaccines 
based on the National Advisory Committee on Immunization (“NACI”) or other expert 
advisory committee recommendations, as well as on local epidemiological, program, 
and financial considerations.9 
 
Manufacturers of vaccines must secure from the federal government a license to market 
any vaccine in Canada.  Vaccines used in Canada are approved and licensed by the 
Bureau of Biologics and Radiopharmaceuticals of the Health Protection Branch, Health 
Canada.  In addition, vaccines continue to be monitored after approval.  The Canadian 
Adverse Events Following Immunization Surveillance System (“CAEFISS”) is a national 
monitoring system for reporting adverse events and suspected adverse events 
following immunization.10   
 
Currently, only two provinces, Ontario and New Brunswick, ensure wide-scale 
immunization through legislation that directly targets children in school.11  In Ontario, 
the Immunization of School Pupils Act places a statutory duty on parents to have their 
children immunized according to the prescribed program of immunization.12  Failure to 
comply with the legislation is a summary conviction offence and is grounds for 
suspension of an unvaccinated pupil from school.  In practice, school and public health 
authorities periodically require proof of vaccination of pupils whose vaccination 
records are not on file.  Parents of unvaccinated students are then given an opportunity 
                                                 
6 Public Health Agency of Canada, National Immunization Strategy, online: Public Health Agency of Canada <http://www.phac-
aspc.gc.ca/publicat/nis-sni-03/pdf/nat_imm_strat_e.pdf>. 
7 Ibid. 
8 Manitoba law Reform Commission, Compensation of Vaccine-Damaged Children (Report # 104) (Winnipeg: Law Reform 
Commission, 2000) at 4. 
9 Supra note 6 at 4. 
10 Law Reform Commission of Saskatchewan, Consultation Paper: Vaccination and the Law (Saskatoon: Law Reform 
Commission, 2007) at 5. 
11 Supra note 3 at 204. 
12 Immunization of School Pupils Act, R.S.O. 1990, c. I.1. 
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to either vaccinate their children, or file an exemption for philosophical reasons, before 
further action is taken.13  In other provinces that do not make routine vaccination 
mandatory, public health legislation permits mandatory vaccination to be ordered 
during an epidemic.14 
 
In addition to direct legal enforcement of vaccination recommendations, most 
provincial and territorial governments have adopted a proactive approach to ensuring 
all children in the province are fully immunized.  Thus, in cooperation with local school 
boards, programs are established that provide for routine vaccinations to be 
administered in schools.  As well, governments engage in mass promotional campaigns 
that utilize all manner of print and broadcast media to reach the broader public.15 
 
Seasonal flu vaccines are administered in Canada in the same manner as routine 
childhood vaccines.  Decisions on vaccine delivery and the administration of flu clinics 
is a provincial and territorial responsibility.  Each province and territory must assess its 
capacity to delivery immunization clinics and then make decisions considering the cost 
of the vaccine.  About 10 million doses of influenza vaccine are distributed annually 
during the flu season in Canada.16 
 
Even in provinces and territories that do not make vaccination compulsory, there is 
considerable governmental and social pressure to participate in the immunization 
process.  The government promotes, encourages, and facilitates the complete 
vaccination of all children in each province and territory.  Parents are persuaded to 
place great reliance in the integrity and safety of the routine childhood immunization 
system and to expose their healthy children to it.17  Furthermore, both WHO and the 
Canadian Public Health Association (“CPHA”) have strongly urged people to receive 
the new H1N1 vaccine.  CPHA urges all Canadians to be immunized against H1N1, 
                                                 
13 Supra note 10 at 28. 
14 See for instance, The Public Health Act, 1994, S.S. 1994, c. P-37.1, s. 45(1). 
15 Supra note 3 at 204. 
16Health Canada, Influenza (“The Flu”), online: Health Canada <www.hc-sc.gc.ca/hl-vs/iyh-vsv/diseases-maladies/flu-grippe-
eng.php>. 
17 Supra note 8 at 15. 
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declaring that “the important health benefits the vaccine offers far outweigh any 
potential risks.”18  
 
II. BENEFITS OF VACCINES AND IMMUNIZATION PROGRAMS 
 
Immunization, the process by which the body’s own protective mechanisms are primed 
to thwart the invasion or multiplication of pathogens, has been described as effective 
and relatively inexpensive, simple, and easy to deliver.19  Childhood immunization was 
one of the foremost public health measures of the twentieth century.  It allowed control 
and prevention of many diseases from which morbidity and mortality were 
staggering.20  There is undoubtedly a great benefit to having vaccinations available on a 
wide scale.  In the United States, prior to the availability of a vaccine, deaths resulting 
from pertussis were seventy per million in the 1920’s.  Vaccine use reduced this figure 
to seven per million by the mid 1950’s.  It has been estimated that use of the DTP 
vaccine prevents approximately 322 000 cases of pertussis per year in the United 
States.21 
 
High vaccination rates, particularly among school-age children, are necessary to 
maintain sufficient immunity in the population to prevent outbreaks of infectious 
diseases.  Outbreaks can be prevented only when immunity rates are high enough that 
it is unlikely that infected and susceptible individuals will come into contact.  Even in 
an immunized population, an outbreak can occur if clusters of susceptible individuals 
remain.  Since school-aged children usually have the highest susceptibility to vaccine-
preventable diseases, childhood immunization has been identified as a particularly 
effective public health measure.  Accordingly, vaccination protects not only the children 
who receive the vaccination and develop immunity, but also children who have been 
                                                 
18 “Canadian Public Health Association urges Canadians to get vaccinated against H1N1: Making complex decisions on 
immunization simpler with credible information” Canadian Business (29 October 2009), online: Canadian Business 
<http://www.canadianbusiness.com/markets/cnw/article.jsp?content=20091029_094502_4_cnw_cnw>. 
19 Kathleen R. Stratton, Cynthia J. Howe & Richard B. Johnson Jr., eds., Adverse events associated with Childhood Vaccines: 
Evidence bearing on causality (Washington, D.C.: National Academy Press, 1994) at 310. 
20 Ibid.  
21 Patricia Carmen Murray, “DTP Vaccine Related Injury: An examination of proposed Vaccine Injury Compensation 
Legislation” (1997) 3 J. Contemp. Health L. & Pol’y 233 at 233. 
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vaccinated but fail to develop immunity, children who are unvaccinated, and 
susceptible adults in the community.22 
 
Public health officials point out that high rates of vaccination coverage are required to 
prevent outbreaks.  This is a result of what is sometimes called the “herd effect.”  When 
most of the population that is most at risk is immunized, an infectious disease will not 
be able to spread in the population to those who lack immunization.  But when 
vaccination rates are too low to produce the herd effect, then those who lack 
immunization are at risk.  Health Canada regards the optimum coverage to be 95% of 
the target population.23   
 
Each province/territory and its people benefit greatly from immunization.  The process 
not only provides personal protection to the recipient from disease, but also provides 
protection for the whole community by reducing the incidence of communicable 
disease.  This phenomenon results in a significant savings to government via reduced 
health care costs and to businesses by avoidance of a loss of productivity arising from 
the parental care of sick children.  Estimates of savings due to immunizations have been 
in the billions of medical and health-related dollars.24  Furthermore, there is an increase 
in work productivity when fewer individuals are suffering from illnesses that may keep 
them away from school or work for extended periods of time.  From an economics-
based approach, sick leave translates into less productivity, which impedes the growth, 
capital, and competitiveness of a nation.  Childhood vaccination is, therefore, not 
merely a selfish act; it is an altruistic act to the advantage of the whole community.25 
 
The wide-spread benefit of immunization programs is apparent.  The Canadian 
National Report on Immunization (1996) describes vaccination as “a cornerstone of 
improving the health of people worldwide,” and as “the most cost-beneficial of all 
prevention strategies, resulting in huge savings to society and to health-care systems.”26   
                                                 
22 Supra note 10 at 31. 
23 Ibid. at 5. 
24 Supra note 8 at 15. 
25 Ibid. 
26 Canada, Public Health Agency of Canada, Canadian National Report on Immunization, 1996, vol. 23S4 (Ottawa: Canada 
Communicable Disease Report). 
 InfraRead: DJLS Online Supplement Vol. 1 84 
Next to clean water, no single intervention has had so profound an effect on reducing 
mortality from childhood diseases as has the widespread introduction of vaccines.27   
 
III. RISKS OF VACCINES AND IMMUNIZATION PROGRAMS 
 
Whereas the benefits of national immunization programs are obvious, the drawbacks 
are not as apparent and indeed may be hidden from the public gaze.  One of the major 
concerns is the serious adverse consequences of routine vaccinations that occur in a 
significant number of children each year.28  The term adverse event following immunization 
(“AEFI”) is defined by WHO as a medical incident that takes place after an 
immunization, that causes concern, and that is believed to be caused by the 
immunization.29  The majority of adverse effects suffered from vaccines are minor and 
short term.  Some tenderness and redness may be experienced at the site of the 
vaccination and the individual may have a low fever.  In exceptional circumstances, the 
consequences may be serious, such as high fever, systemic joint or muscle pain, seizures 
or anaphylactic shock.  In rare situations, an individual may suffer permanent disability 
such as neurological damage, or may even die.30  
 
According to the Public Health Agency of Canada, a total of 3,625 adverse events 
following immunization reports were received for vaccines given in 2004.  The three 
most commonly reported adverse events were local reactions (32.4%), allergic reactions 
(31.7%), and fever (23%).31  Although more serious reactions are rare, they obviously are 
of greater concern to both parents and public health officials.  Some of the more serious 
reactions include: encephalitis in about .06% of reported adverse effects, infection with 
live virus, Guillain-Barre Syndrome in about 0.07% of reported adverse effects, and 
anaphylactic shock in about 0.37% of reported adverse effects.32 
 
                                                 
27 Supra note 19 at 310. 
28 Supra note 3 at 206. 
29 World Health Organization, Vaccine Safety and Adverse Events Following Immunization, online: World Health Organization 
<http://www.who.int/immunization_monitoring/routine/immunization_adverse/en/index.html>. 
30 Supra note 8 at 1. 
31 Canada, Public Health Agency of Canada, Canadian National Report on Immunization, 2006, vol. 32S3 (Ottawa: Canada 
Communicable Disease Report) at 31. 
32 Supra note 10 at 14. 
Vol. 1 Vaccine-Related Injuries 85 
Much speculation surrounds discussions of the risk of contracting Guillain-Barre 
Syndrome (“GBS”), an autoimmune disorder that affects the peripheral nervous system, 
from the flu vaccine.  Since 1997, during 12 annual seasonal influenza vaccine 
campaigns, a total of 79 cases of GBS have been reported following influenza vaccine.  
This is an average of 7 cases per year, with a yearly range of 1 to 14 cases.33  According 
to WHO, data is conflicting as to whether a causal relationship exists between modern 
influenza vaccines and GBS.  They claim that if one exists, the risk is estimated to be 
very low (no more than 1 to 2 cases per million doses).34  With regard to the H1N1 
vaccine, the Public Health Agency of Canada claims that since GBS is so rare, it is 
usually not seen as an adverse event following immunization in the clinical trial stage.  
In order to assess the potential risk, if any, of GBS following H1N1 flu vaccine, a larger 
population would need to be observed.35 
 
Some studies have also attributed the dramatic increases of autoimmune disorders such 
as asthma and diabetes in the last two decades, as well as the significant rise in autism 
and sudden infant death syndrome, to the widespread use of vaccines.36  Much of this 
concern has arisen due to the use of thimerosal additives in vaccines.  Thimerosal is a 
mercury-containing organized compound that is widely used as a preservative in 
biological and drug products to prevent life-threatening contamination of harmful 
microbes.37  Most influenza vaccines available in Canada contain minute amounts of 
thimerosal.  However, despite the concern over the use of mercury, a number of studies 
indicate that the evidence does not support a causal link between vaccination and 
neurological disorders or death.38  
 
With regards to the new H1N1 vaccine, although WHO claims that it has been 
thoroughly tested, is safe, and does not create harmful effects, they have admitted that 
even very large clinical studies will not be able to identify possible rare events that can 
become evident when pandemic vaccines are administered to many millions of people.  
                                                 
33 Supra note 1. 
34 World Health Organization, Safety of Pandemic (H1N1) 2009 Vaccines, online: World Health Organization 
<http://www.who.int/csr/disease/swineflu/frequently_asked_questions/vaccine_preparedness/safety_approval/en/>. 
35 Supra note 1. 
36 Supra note 3 at 207. 
37 Regina Moreland, “National Vaccine Injury Compensation Program: The Potential Impact of Cedillo for Vaccine Related 
Autism Cases” (2008) 29 J. Legal Med. 363 at 370. 
38 Ibid. 
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They have noted that these can only be assessed when a vaccine is in widespread use.39   
Therefore, although extensive clinical and non-clinical testing has been performed on 
the new vaccine to assess its safety, severe adverse effects may still present when the 
vaccine is delivered to Canadians en masse. 
 
Vaccine injuries can be the result of various factors.  Many times, vaccine-related 
injuries are not due to the fault of any one party.  Usually, the vaccine is manufactured 
by a drug company and administered by health officials in strict compliance with 
federal and local laws.  Vaccines represent a special class of health products in that they 
can cause harm despite proper manufacture, distribution, and administration.  Injuries 
may be as a result of a genetic predisposition or as a result of the very nature of the 
vaccine itself.40  The vaccine may further be contraindicated because of allergy, pre-
existing illness, immunosuppression, or age.41  
 
Vaccine injuries can, however, also be caused by the negligence of one or more persons. 
Contamination, adulteration, improper configuration, or other errors in the 
manufacturing process, inadequate testing, or improper labeling can result in defective 
vaccines.  Even if the vaccine is not defective, injury may occur if the vaccine is 
administered improperly or in an improper dosage.42    
 
Furthermore, lack of informed consent may cause injuries due to the fact that an 
individual may have declined to receive the vaccine if they had been properly informed 
of all of the material risks.  The Supreme Court of Canada in Reibl v. Hughes held that 
doctors have a duty to disclose all material risks of a proposed procedure, which 
includes those risks that may have a low probability but grave results.43  It is therefore 
imperative that individuals be provided with full disclosure of all risks and benefits 
when making the decision to vaccinate either themselves or their children.  However, 
both empirical studies and anecdotal evidence indicate that individuals are rarely 
                                                 
39 Supra note 34. 
40 Supra note 3 at 208. 
41 Wendy K. Mariner, “Compensation programs for vaccine-related injury abroad: a comparative analysis” (1987) 31 Saint Louis 
U.L.J. 599 at 599. 
42 Ibid. 
43 Reibl v. Hughes, [1980] 2 S.C.R. 880, 33 N.R. 361. 
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guided through a full informed consent process with respect to vaccines.44  This 
discrepancy may be attributed to a number of factors.  It may be a result of continued 
acceptance by the public and those who administer vaccines of the status quo of routine 
vaccine administration systems.  Many parents or patients themselves may follow their 
doctor’s advice without engaging in independent decision-making.  Furthermore, due 
to time constraints, disclosure when it does exist may consist only of a pamphlet or fact 
sheet, which is arguably insufficient to meet the standard as prescribed by the common 
law.45  Finally, disclosure may not be occurring because many physicians themselves 
may not be aware of all the risks and contraindications of vaccination.46    
 
It is therefore apparent that there are serious risks involved with vaccination, both from 
vaccines themselves and through the system of immunization.  Although serious 
adverse events following immunization are rare, when they do occur they can have 
severe, sometimes permanent damaging effects, and in some cases can even cause 
death.  As will be discussed below, the current system for addressing the needs of those 
who have suffered from the risks of vaccines is inadequate.  It may be impossible to 
eliminate all risks from vaccinations.  However, Canada can create a system that fairly 
and efficiently compensates those who have been injured in an act that benefits not only 
those who have suffered harm, but society in general. 
 
IV. VACCINE INJURIES AND THE TORT SYSTEM 
 
In Canada, with the exception of Quebec, compensation for adverse reactions to 
vaccination is mediated under principles of tort law.  Entitlement to compensation 
depends upon whether a manufacturer or some other person, such as the administering 
physician, is legally liable for causing the injury.47  The medical malpractice system 
assumes that a patient should be compensated if, and only if, he or she is injured by the 
fault of a physician or another health care provider.48  In the absence of conduct 
amounting to fault, there is no basis for imposing liability, and consequently, no 
                                                 
44 Supra note 3 at 210. 
45 Ibid. at 211. 
46 Davidson v. Connaught Laboratories, [1980] O.J. No. 153, 14 C.C.L.T. 251. 
47 Supra note 41 at 600. 
48 Robert E. Astroff, “Show me the money!: Making the case for no-fault medical malpractice insurance” (1996) 5 Health L. Rev. 
9 at 10. 
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entitlement to compensation.49  If an action is successful, then the remedy is an award of 
damages which is designed to place the victim in the position that he or she was in 
before the accident occurred, insofar as money can achieve that goal.50   
 
With respect to vaccine injuries, there are two relevant torts that may apply: negligence 
and battery.  The tort of battery in medical procedures exists when a plaintiff has not 
consented to a procedure and is consequently injured by the actions of a physician, 
regardless of the good intent or lack of negligence on the part of the physician.51  Thus, 
proof of a lack of consent for the administration of the vaccine or proof of invalid 
consent (i.e. as when obtained through fraud or misrepresentation), is required, as well 
as proof that the defendant touched the plaintiff.52 
 
The tort of negligence imposes liability for damage caused by the failure of one person 
(the defendant) to take reasonable care for the safety of another person (the plaintiff). 
The plaintiff must prove that the defendant owed the plaintiff a legal duty of care and 
failed to exercise reasonable care causing foreseeable damage to the plaintiff.  The 
plaintiff must establish that “but for” the negligent action of the defendant, the plaintiff 
would not have sustained the injury.53  If the plaintiff is able to prove negligence, the 
defendant may then be able to assert one or more of the defences of voluntary 
assumption of risk (a complete defence), or contributory negligence (which reduces 
damages in proportion to the plaintiff’s responsibility for the damage or the loss).  
Those who suffer vaccine-related disabilities may have a negligence claim against the 
person who administered the vaccine, such as a physician or public health care 
worker.54 
 
Those who administer a vaccine owe a duty of care to vaccine recipients.  This duty has 
two components.  First, there is a duty to give the vaccination with reasonable care and 
skill and in accordance with standard medical practice.  Negligence can arise in a 
number of ways: the vaccine may be improperly stored or prepared; the vaccination 
                                                 
49 Supra note 41 at 601. 
50 Supra note 8 at 8. 
51 Supra note 3 at 213. 
52 Ibid. at 214. 
53 Ibid. 
54 Supra note 8 at 8. 
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may be contraindicated because of the health of the individual; or, possibly, a course of 
vaccinations may be negligently continued in spite of adverse reactions exhibited by an 
individual to each of the preceding doses.55   
 
Second, there is a duty to provide the recipient, or the parent or guardian if the recipient 
is a child, with sufficient information about the material risks and side effects of the 
vaccine to secure an informed consent to the procedure.  Material risks are those which 
a reasonable person in the position of the patient would want to know about when 
deciding whether or not to consent to the medical procedure at issue.  The health care 
professional is obliged to see that the requisite information has been communicated and 
understood.56 
 
A plaintiff has a difficult hurdle to overcome with respect to causation in informed 
consent cases.  The plaintiff must first establish that, on a balance of probabilities, the 
injuries were caused by the vaccine.  The plaintiff then has to show that the decision-
maker would have refused to consent to the vaccination if the required information of 
material risks had been given.  This decision is resolved based on what a reasonable 
person in the particular circumstances of the decision-maker would have done.  If the 
same decision would have been made, then the plaintiff has failed to prove that the lack 
of information caused the injury or illness.57 
 
A plaintiff who suffers an injury by a vaccine may also have a cause of action against 
the manufacturer.  The manufacturer of a vaccine owes a duty of care to the consumers 
of its products.  Negligence may be found in the manufacture of defective vaccines, in 
the failure to provide information about the inherent risks of the vaccine, and in the 
faulty design of vaccines.58  Although a manufacturer has a duty to warn consumers of 
the material risks associated with the use of its product, it can discharge its obligation to 
inform the patient by providing it to a “learned intermediary” such as a physician.59  
Yet, if a product is inherently unsafe due to negligence in developing and testing it, 
                                                 
55 Ibid. at 9. 
56 Ibid. 
57 Ibid. at 10. 
58 Ibid. 
59 Supra note 3 at 213. 
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then the manufacturer is liable for harm caused by the product. The plaintiff would 
then have to show that the adverse effects of the vaccine rendered it unsuitable for use.60 
 
There have been very few, if any, doctrinal changes of any real significance in health 
care liability over the last 50 years.61  A plaintiff, in proceeding with a negligence claim 
against a medical professional, must overcome many difficult hurdles in order to 
receive compensation.  It is questionable whether the tort system is the adequate forum 
to provide proper redress for vaccine-related injuries.  The next section of this article 
will discuss the pros and cons of tort law in general, and the reasons why, in the context 
of vaccine-related injuries, tort law needs to be replaced or supplemented by a no-fault 
compensation system. 
 
V. THE PROS AND CONS OF THE TORT SYSTEM 
 
The ideological premise behind tort law is clear.  The tort notion that individuals should 
be held personally responsible and accountable for the injuries which they cause to 
themselves or to others, when these injuries were reasonably preventable, reflects our 
deep-seated beliefs in morality and justice.62  Advocates of the present tort system assert 
that requiring wrongdoers to pay for the results of their wrongful acts results in a 
number of beneficial consequences: justice, deterrence, education, and compensation.63   
Arguments that tort law should be abolished and replaced by no-fault schemes 
generally focus on tort law’s ineffectiveness and economic inefficiencies in delivering 
these consequences.64  The next section will enquire whether tort law alone is sufficient 
to provide redress for victims of medical errors. 
 
1. Justice 
Many would argue that the most persuasive reason for retaining tort law is that it 
expresses an important principle of justice.65  Lewis Klar argues that “the idea that a 
wrongdoer who injures another ought to be required, both as a moral and a legal 
                                                 
60 Supra note 10 at 17. 
61 Gerald B. Robertson, “A View of the Future: Emerging Developments in Health Care Liability” (2008) Health L.J. 1 at 1. 
62 Lewis N. Klar, “Tort and no-fault” (1997) 5 Health L. Rev. 2 at 3. 
63 Supra note 48 at 10. 
64 Supra note 62 at 3. 
65 Ibid. 
Vol. 1 Vaccine-Related Injuries 91 
obligation, to repair the damage caused by restoring the victim to his or her pre-
accident state, is undeniably a fundamental feature of our system of beliefs.”66  The idea 
of personal responsibility for one’s wrongful conduct is so deeply ingrained in our 
society that, for some, this alone justifies tort law’s continued existence, since tort law is 
the mechanism by which accountability is assessed and, hence, how this imperative is 
realized.67  In sum, to ignore wrongdoing would simply be unacceptable. 
 
A common response to this view is that, in a medical malpractice claim, even if a doctor 
were found to be negligent, liability insurance would cover most losses.68  The 
argument for bringing the wrongdoer to justice becomes less convincing when an 
insurance company, instead of the individual medical professional, pays for the tort 
claim. 
 
While this reasoning is valid, it is important to note that a tort action still holds the 
medical professional accountable to answer to the victim.  A finding of liability can 
seriously hurt one’s reputation and goodwill.   Additionally, insurance premiums will 
go up for those with bad claims records.69  Furthermore, for the victim who was injured 
by the negligent conduct of the health professional, the source of compensation may not 
be as important as the ability to place fault and accountability.70   
 
2. Deterrence 
The deterrent effect of tort liability is also commonly cited as a goal of tort law.  The 
threat of tort liability and the imposition of financial sanctions on those who fail to take 
reasonable care will, at least in theory, encourage careful behaviour.71  Some studies 
have indicated that tort liability does, in fact, deter unreasonable behaviour and that 
when no-fault schemes are implemented, accident rates and accident costs increase.72  
On a theoretical level, however, it has been argued that people’s conduct and concern 
for others is more likely a reflection of human psychological traits, attitudes, habits, and 
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personal codes of conduct rather than a desire to avoid tort liability.73  Despite this 
possibility, in some settings and for some defendants, such as health-care professionals 
(where there is a hypersensitivity to findings of liability), general deterrence may have a 
powerful effect.74   
 
The problem with this concern by health professionals for incurring liability is the 
resulting phenomenon of defensive medicine.  The concept behind defensive medicine 
is that doctors act defensively in order to avoid law suits.75  Due to a fear of accusations 
and liability, litigation induces health care providers to practice inefficient medicine, 
unnecessarily using medical resources to protect against law suits and also refusing to 
provide care or adopt new methods of treatment for fear of increased liability 
exposure.76  Notwithstanding these apparent negative effects, defensive medicine can 
also arguably create situations wherein doctors are more careful and meticulous in their 
dealings with patients, despite the cost it has on the medical system, and that therefore 
fewer cases of negligence and failure to inform will arise.77 
 
3. Education 
Tort law is also said to provide education.  This is so because activities regulated by tort 
law tend to arise through ignorance more than intentional departures from accepted 
norms and standards of behaviour.78  In the medical malpractice context, this function 
of tort law is thought to be very important, since standards of care are continually 
changing.  In tort litigation, current standards of care are reviewed, tested, and 
advanced.  It would seem, therefore, that without tort law, practice standards would 
remain relatively static.79  The current system, it is argued, achieves the important 
functions of enhancing practice standards and educating doctors about the current 
minimum standards of care and other legal issues through the publication and publicity 
of important court decisions.80  
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4. Compensation 
Finally, compensation is also a generally accepted goal of tort law.  It is thought to be 
just that the defendant must compensate the person who he or she has wronged and 
that this amount be measured by the loss suffered by the plaintiff.81  The idea behind 
compensation is that the victim will be fully restored by the wrongdoer to his or her 
pre-accident position.  The idea of full compensation is a fundamental part of tort law, 
so much so that victims are compensated for even intangible losses.82  In cases where 
fault is proven, compensation includes, but is not limited to, recovery for pain and 
suffering, replacement of lost past and future income, costs of future care, gross-up for 
income tax, and pre-judgment interest.83   
 
One commonly cited flaw of the current system, however, is that it does not actually 
achieve its goal of compensating victims of iatrogenic injuries, since only a small 
percentage of those injured during their stays in the hospital actually receive any form 
of compensation.84  Under the current system, the means of compensating have been 
called subjective, intuitive, and unequal.85  It heavily overpays some claimants, while 
underpaying or denying others who are equally or more deserving.86  As a result, the 
tort system has been characterized as a “lottery” because of its unpredictability and 
tendency to award disproportionate compensation to similarly situated plaintiffs.87   
 
In 2008, 884 lawsuits were commenced against Canadian doctors.  Of the actions that 
have proceeded to trial, only 13 judgments have been rendered in favour of the 
plaintiffs.88  It is believed that only approximately one-third of medical malpractice 
claimants per year are likely to receive any compensation.89  Some reports go as far as to 
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say that perhaps as few as 2% of the people who suffer injury as a result of medical 
negligence actually receive any compensation.90    
 
Furthermore, many victims choose not to litigate, and therefore receive no 
compensation for their injuries.  In the United States, the Harvard Medical Practice 
Study physician review concluded that only one negligence claim is made for every 7.5 
injuries caused by negligence.91  There are many reasons why victims choose not to 
litigate.  Often patients are unaware that they have suffered an iatrogenic injury; the 
plaintiff must prove a breach of the medical standard of care; it is very difficult for a 
lawyer to prove even a meritorious malpractice case;92 the plaintiff must prove 
causation, which can be very difficult in a complex medical malpractice claim; and, 
cases can be lengthy and expensive.  In sum, the expense, time, and difficulty of 
initiating and maintaining a malpractice action limit plaintiff access to tort 
compensation.93  In fact, a number of respected judges over the last 20 years have 
expressed regret that patients deserving of compensation are precluded from it by the 
present requirements of tort law.94   
 
It appears that tort law does offer several beneficial effects.  Although there may be 
severe drawbacks and inadequacies of the current system, it may end up causing more 
harm than good to abandon the entire medical malpractice system for no-fault 
compensation.  Despite this possibility, however, in the isolated context of vaccine 
injury, tort law, as will be discussed below, is not well-equipped to provide adequate 
and sufficient redress. 
 
VI. PROBLEMS WITH THE TORT SYSTEM FOR VACCINE-RELATED INJURIES 
 
Very few vaccine injury claims have been litigated in Canada. Those that have been 
have not been favourable to the plaintiffs.95  Specifically, plaintiffs in vaccine injury 
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claims have a significant hurdle in proving causation.  Because of this problem, there is 
a general lack of success of vaccine-damaged plaintiffs in Canada to date.96   
 
To be successful in a negligence claim, the plaintiff must prove on a balance of 
probabilities that the injury was caused by the defendant’s acts or omissions.  This is 
especially difficult in many vaccine injury cases.  The first element of causation in a 
vaccine liability case is general scientific causation – the ability of the product to cause 
the harm.97  Unfortunately, the mechanisms of vaccine damage are not well 
understood.98  Adverse effects of vaccination are reported when there is a temporal link 
between vaccination and symptoms.  However, further research is still needed in many 
cases in order to actually establish a causal link.99  For example, a link between Guillain-
Barre syndrome and vaccination has not been satisfactorily demonstrated in the twenty 
years since it was first suspected.100   
 
If a plaintiff is successful in establishing general scientific causation, then the plaintiff 
next has to prove legal causation.  As was set out in Barnett v. Chelsea & Kensington 
Hospital Management Committee, the plaintiff must show that “but for” the negligent 
action of the defendant, the plaintiff would not have been injured.101  In order to do this, 
the plaintiff must prove that the vaccine indeed caused the particular plaintiff’s injury.  
As with general scientific causation, this is also a scientific enquiry that is difficult to 
prove.  It is often difficult to determine whether the harm was incidentally related to the 
vaccine or whether the vaccine directly caused it.102   
 
In an action for lack of informed consent, the plaintiff must prove that he or she would 
have declined to consent had the risks been disclosed.103  As discussed above, the 
doctrine of informed consent creates several problems for the plaintiff in a vaccine 
injury claim.  Ideally, when a parent decides to vaccinate a child, he or she should be 
informed of all of the material risks of vaccination and of a refusal to vaccinate.  The 
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extent and degree of disclosure of the risks of vaccines is high because the recipient is 
not ill.104  The practice of providing information about vaccination appears to vary, 
however, from providing a pamphlet or information sheet with general information 
about vaccination, to more detailed discussion with the patient or parent; some parents 
do not believe that they are given adequate information105 
 
Furthermore, the role of consent is somewhat different if vaccination is mandatory. 
Parents are still able to refuse vaccination for their children in jurisdictions such as 
Ontario and New Brunswick where vaccination is compulsory, but the vaccination may 
be administered without positive consent if the parent has not filed a statement in the 
approved form to claim an exemption.106  This requirement may contribute to a sense 
that vaccination programs have not been fully justified to the public.107   
 
Creating further difficulty with informed consent is the problem that the question 
asking what the decision-maker would have decided if the required information on 
material risks had been given is not based on what that particular decision-maker 
would have decided, but instead on what a reasonable person in the particular 
circumstances of the decision maker would have decided.  This is what is known as a 
modified objective standard for legal causation.  In almost all situations, a full 
explanation of the risks and benefits of vaccination and the risks and consequences of 
the disease the vaccination is meant to prevent will lead reasonable persons to proceed 
with the vaccination.108  Considering the alternatives to vaccination, namely a higher 
probability of contracting a serious disease, balanced with the comparatively 
insignificant associated risks, in a situation where the risks and benefits have been 
disclosed, it is inevitable that a reasonable person would choose vaccination.  Where the 
benefits clearly outweigh the risks, the plaintiff is placed in the almost impossible 
situation of having to establish that he or she would have refused vaccination.  
 
                                                 
104 Supra note 8 at 10. 
105 Supra note 10 at 8. 
106 Ibid. 
107 Ibid. 
108 Supra note 8 at 10. 
Vol. 1 Vaccine-Related Injuries 97 
The situation is a little different, however, in product liability cases where the claim for 
negligence for failure to warn is against the manufacturer.  The standard applied in 
these cases is the subjective standard, asking what that particular plaintiff would have 
decided if he or she had been properly informed.109  This different analysis of causation 
is thought to reflect the distinction between the manufacturer-consumer relationship 
and the doctor-patient relationship.110  However, the manufacturer may discharge its 
duty to warn the consumer through the learned intermediary rule, which dictates that 
the manufacturer must take adequate steps to ensure that the intermediary, usually a 
doctor, is provided with the relevant information on the product.  If it has provided this 
information to the learned intermediary, then it cannot be held liable for a failure to 
warn. 
 
Finally, the plaintiff in vaccine injury cases faces the problem of indeterminate 
defendants.  This occurs when the plaintiff is unable to point to one particular 
defendant among a group of negligent defendants as having actually caused the 
plaintiff’s injury.111   For a vaccine injury case, there may be more than one 
manufacturer of a type of vaccine that have all been negligent, but the plaintiff cannot 
establish which of the negligent manufacturers supplied the vaccine that caused the 
plaintiff’s injury.  If a plaintiff cannot prove that it was more likely than not that one 
particular manufacturer supplied the vaccine that caused the injury, then the claim 
must fail. 
 
Because of the difficulties that plaintiffs face in the context of vaccine injuries, there has 
been much judicial suggestion that the normal process of litigation is inadequate to deal 
with claims of this nature.  Some examples to this effect are discussed below. 
 
VII. EXAMPLES FROM CASE LAW 
 
The difficulty a plaintiff faces in establishing scientific causation is illustrated in the case 
Rothwell v. Raes.112  The plaintiff, Patrick Rothwell, alleged that the pertussis vaccine 
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caused severe physical and mental disability.  About one month after receiving his third 
shot of the vaccine at the age of five months, Patrick began to show signs of 
developmental abnormality.  The plaintiff sued the manufacturer, Connaught 
Laboratories, the physicians who administered the vaccine, and the Crown, who had 
distributed the vaccine.  A broad range of expert testimony and medical research was 
canvassed by the trial judge.  The court ultimately held that the plaintiff had not 
established on a balance of probabilities either that the pertussis vaccine was capable of 
causing injury of the kind suffered by the plaintiff, or if it was capable of causing such 
injuries, that it had done so in the case under consideration.  In concluding, Justice Osler 
commented on how “the normal process of litigation is an utterly inappropriate 
procedure for dealing with claims of this nature.”113  He went on to quote Justice Krever 
from Ferguson v. Hamilton Civic Hospitals, who stated: 
I confess to a feeling of discomfort over a state of affairs, in an enlightened 
and compassionate society, in which a patient, who undergoes a necessary 
procedure and who cannot afford to bear the entire loss, through no fault 
of his and reposing full confidence in our system of medical care, suffers 
catastrophic disability but is not entitled to be compensated because of the 
absence of fault on the part of those involved in his care.  While it may be 
that there is no remedy for this unfortunate and brave plaintiff and that 
this shortcoming should not be corrected judicially, there is, in my view, 
an urgent need for correction. 114 
He and many other judges have noted how the current tort process holds out very little 
promise for an efficient and fair remedy for those children who suffer vaccine-related 
injury and illness.  In Rothwell, the trial judgment in favour of the defendants was not 
rendered until nine years after the vaccine in question was given.  An appeal to the 
Ontario Court of Appeal was dismissed two years later.  It has been estimated that the 
legal costs of the litigation exceeded $1 000 000.115  This type of uncertainty, delay, and 
expense is unfortunately a common phenomenon in the tort process. 
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The inability of the tort system to provide redress to vaccine-injured plaintiffs is further 
illustrated in the recent Ontario case, Morgan v. Metropolitan Toronto (Municipality).116  
The plaintiff, Lucia Morgan, sued the City of Toronto for negligently administering the 
hepatitis B vaccine.  She allegedly developed chronic fatigue syndrome as a result, 
which dramatically and permanently affected her quality of life.  The plaintiff was a 
social worker who got the vaccine after being urged to do so by her employer.  The 
plaintiff argued that the City breached the standard of care in failing to adequately 
disclose the risks of the vaccine.  The trial judge, however, concluded that the 
information provided adequately reflected the state of knowledge of the known risks of 
the vaccine at the time.  Furthermore, the trial judge ultimately concluded that even if 
all the risks had been adequately disclosed, Lucia would nevertheless have opted to 
receive the shots.   
 
In her concluding remarks, the trial judge, Mary Anne Sanderson, commented on how 
“the road to protecting public health should not be paved with individual victims.  Fair, 
meaningful, no-fault compensation should be made available to individuals suffering 
from serious adverse side effects of vaccines.”117  She went on to note that: 
At present, as this case illustrates, even when it can be credibly postulated 
that a vaccine has caused serious adverse consequences, the barriers 
standing in the way of recovery are formidable.  A tort claimant who 
suspects a vaccine has caused her damage will not likely be working and 
able to afford the costs of litigation.  Complex and protracted litigation 
such as this is notoriously costly, given the need for expert scientific 
evidence and medical proof.  Even those able to afford such costs would 
likely be met (as here) with experts stridently touting vaccine safety.118 
It took 12 years between Ms. Morgan falling ill and a judgment being rendered.  Her 
case is yet another example of how our system is failing victims who are injured by 
vaccines that yield widespread public benefits. 
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A final example of how the tort system has failed plaintiffs injured by vaccines is the 
Supreme Court of Canada case, Lapierre v. Québec (Attorney General).119  The unsuccessful 
litigation of the plaintiff, Nathalie Lapierre, was what prompted the Quebec 
government to implement a no-fault vaccine injury compensation plan.  One week after 
being vaccinated for measles, Nathalie suffered acute viral encephalitis which left her in 
a state of permanent and almost total disability.  An action was brought against the 
government of Quebec, which in turn joined the manufacturer and the distributor of the 
vaccine.  The trial judge found a causal link between the vaccine and the disability, but 
found that none of the defendants were negligent.  The case reached the Supreme Court 
of Canada on the issue of whether the government can be held strictly liable for the 
adverse consequences of vaccination programs funded and supported by it.  The Court 
declined to impose liability.  In concluding, the Court quoted Justice McCarthy: “In my 
opinion, an obligation independent of any fault in circumstances such as those of the 
case at bar would be an excellent thing, but it does not exist in our law at present.”120  
The message from this case is that proof of negligence is an essential component of tort 
liability, and that there is little likelihood of negligence and causation being established 
against government, vaccine manufacturers, or health care professionals for vaccine 
injuries.121   
 
VIII. NO-FAULT COMPENSATION PROPOSALS 
 
The concern over the inadequacies of the current tort system has led many to push for 
the implementation of no-fault compensation schemes.  The basic premise behind no-
fault is simple: those persons who have been injured in an accident and who have 
become disabled as a result should receive compensation for their injuries and losses 
without regard to the cause of their accidents.122  The principle is that “fault” should 
play no role either in the eligibility for compensation or level of compensation 
decisions.123  There are innumerable variations of these systems, ranging from partial to 
full compensation and from “pure” no-fault to a mixed tort/no-fault system.124  One 
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alternative to a fault system is to implement limited no-fault plans utilizing specified 
events.  A no-fault vaccine-related injury compensation scheme to specifically address 
vaccine-related injury and illness has been recommended to supplement the tort 
scheme.  A no-fault system would provide compensation for those who can establish 
that they suffered harm from a vaccination, regardless of fault. 
 
Many jurisdictions throughout the world have introduced special compensatory 
initiatives to address vaccine-related injury and illness.  A similar rationale underlies 
most of the existing programs: where individuals receive vaccinations required or 
recommended by government in the public interest, and they are injured as a 
consequence, government has a special responsibility to provide compensatory support 
regardless of whether or not negligence can be proven.125   
 
There are many advantages proposed for no-fault schemes.  Under a no-fault plan, 
more victims will recover their economic losses, with much less delay than under the 
present scheme.  Health care providers may be more likely to reveal the nature of the 
injury to the patient because the provider would no longer be held financially liable. 
Under a no-fault system, all patients would have the security of a prompt award equal 
to their economic loss, without incurring significant legal or expert fees.  In addition, 
patients would be able to avoid the uncertainty of a long and costly litigation process, 
with potentially no recovery.  Finally, a no-fault system would eliminate the unfairness 
of the current tort system against plaintiffs who cannot afford the best lawyers and 
expert witnesses.126 
 
Furthermore, a no-fault compensation plan for vaccine-related injuries would reflect the 
reciprocal relationship between the individual receiving the vaccine and society in 
general.  As previously stated, the general population as well as the individual recipient 
benefit from vaccination.  Michelle Mello argues that, “among vaccinees, the injured 
and the uninjured pay unequal shares of the social cost of producing the shared good of 
herd immunity. In other words, the uninjured are (unintentionally) free-riding on the 
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injured.”127  To balance this inequality, Mello argues that fairness and solidarity both 
militate in favour of a safety net for those who bear the burden of injury.128  The 
argument in favour of compensating those who are injured is even stronger in 
provinces that require mandatory childhood vaccination.  Individuals who are harmed 
by the exercise of coercive power should be offered restitution, to the extent that the 
government can reasonably provide it.129 
 
Although the adoption of a no-fault scheme would appear to create an efficient and 
relatively uncomplicated means for compensating victims of vaccine injuries, there are 
certain factors that are cause for some concern.  First, as was pointed out by the 
Manitoba Law Reform Commission, such a scheme would differentiate unfairly 
between those who suffer a childhood vaccine accident and those who suffer some 
other kind of medical accident.130  The former would receive guaranteed benefits and 
the latter would need to rely on the tort system, with uneven results.  The distinction 
may, however, be justified on the grounds that the former participate in a public health 
campaign that benefits not only the receiver of the vaccine but the population in 
general, and they have received treatment unrelated to any personal current illness.131   
 
Second, the establishment of a compensation plan for victims of vaccine accidents may 
undermine the public confidence in an important public health initiative, and may lead 
to a lowering of vaccination rates among the general disadvantaged public.132  However, 
it is unlikely that any governmental initiative which depends on public support and 
confidence will prosper by unduly discounting risks and disadvantages.  The open 
discussion of all material risks is essential for a successful immunization program.133 
 
Third, the development of a no-fault plan may diminish the power of tort law to 
positively influence the conduct of health care professionals and manufacturers.  It is 
argued that with a no-fault scheme, there will be no effective deterrent against wrongful 
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behaviour, and therefore risky conduct will increase.134  In theory, this may be correct, 
but the experience of health care professionals and manufacturers in relation to vaccine 
injuries is one in which there is no reported Canadian case where anyone has been held 
liable.  Since it is already almost impossible to find liability in vaccine-injury cases, 
moving to a no-fault scheme will likely not create a great loss in deterrence.  
Furthermore, by supplementing the tort system with a no-fault scheme, a plaintiff 
would still be able to bring a tort claim, thereby retaining the deterrent effect of tort law. 
 
Fourth, critics of no-fault proposals argue that they are more expensive to finance and 
administer than the current tort system.135  For example, the costs of the ambitious and 
comprehensive no-fault system in New Zealand escalated substantially from what was 
predicted, and has led to a major revamping of the scheme.136  However, whether a no-
fault scheme would cost more depends on the design of the compensation program.137   
 
Fifth, the elimination of compensation for pain and suffering is seen as a controversial 
aspect of no-fault systems.  No-fault systems generally do not offer victims any 
compensation for non-pecuniary losses, such as pain and suffering, or loss of enjoyment 
of life, and have ceilings on pecuniary losses, such as loss of earning capacity.  There 
may also be restrictions on what can be claimed as loss of earnings, because (generally) 
potential earnings for those not currently employed are not compensated for by no-fault 
schemes.138  However, given the fact that few victims receive compensation even for 
pecuniary loss within the tort system, it might be more fair to offset the elimination of 
pain and suffering by guaranteeing economic loss compensation to a greater number of 
victims.139 
 
A final problem with no-fault systems is the difficulty in proving causation.  The victim 
under a no-fault system faces the same hurdles that he or she would face under the tort 
system in having to prove that the vaccine caused the injury or illness.  In order to 
receive compensation, the claimant must establish a causal link between the vaccine and 
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the disability or death on a balance of probabilities.  Under the Quebec no-fault 
vaccination scheme, the causation requirement has led to the same result as in the tort 
system – very few victims are able to meet the burden of proof when it comes to vaccine 
injuries.140  From its inception until the year 2000, there have been only 117 claims under 
the Quebec scheme.  Of these claims, only 20 have been compensated, with the average 
pay out being $135 000.  It is thought that the low number probably reflects the 
difficulty in establishing causation.141  However, this criticism applies to all medical 
compensation arrangements, not just to no-fault systems.  Although no compensation 
scheme is perfect, it is suggested that, on balance, some version of a no-fault scheme 
will provide a better option than the current tort/fault-based system.     
 
IX. NO-FAULT VACCINE COMPENSATION SCHEMES IN OTHER JURISDICTIONS 
 
Public compensation programs for vaccine injury have been established in numerous 
jurisdictions, including Germany (1961), France (1964), Japan (1970), Switzerland (1970), 
Denmark (1972), New Zealand (1974), Sweden (1978), United Kingdom (1979), Québec 
(1987), United States (1988), Taiwan (1988), Italy (1992) and Norway (1995).142  This 
section will describe the programs that have been established in Quebec and the United 
States.  A combination of elements from these two schemes would arguably be ideal for 
the creation of compensation plans for the rest of Canada. 
 
1. Quebec 
Quebec’s no-fault system for vaccination was enacted in 1985 after the unsuccessful 
litigation of Nathalie Lapierre.143  The plan provides compensation to any person, adult 
or child, who suffers “grave and permanent mental or physical damage” caused by a 
designated vaccination, or by a disease contracted from an immunized person, or as a 
result of being a fetus of an immunized person.  If causation is proved and the claimant 
meets other necessary criteria, then compensation is paid in accordance with the 
benefits outlined in the Automobile Insurance Act. 
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The vaccines covered by the plan are listed in a regulation, which is intended to include 
all vaccines approved for use in the province.  The claimant must make a written 
application to a three-member medical assessment committee in the Department of 
Health and Social Services.  The committee is composed of a physician nominated by 
the Minister of Health, a physician nominated by the claimant, and a physician 
nominated by the other two members.144  Compensation is awarded on a no-fault basis; 
negligence need not be proved.  However, a causal relationship between the vaccination 
and the injury must be established on a balance of probabilities. 
 
The decision of the Minister of Health and Social Services may be appealed both on the 
merits of the decision and as to the quantum of compensation to the Commission des 
Affaires Socials.145  The funding for the plan comes from the consolidated revenue fund 
of the province of Quebec.  A limitation is placed on the claimants in that they must 
bring their claims within three years of the date of the vaccination, or in the case of 
death, three years from the death.146  The no-fault plan does not limit any tort claims 
that may be available to the claimant; however, in the event of the recovery of tort 
damages, there must be reimbursement of any indemnities received under the no-fault 
plan. 
 
2. The United States 
The United States’ plan is somewhat different from Quebec’s.  In 1986, the U.S. 
Congress passed the National Childhood Vaccine Injury Act147 in response to worries about 
the safety of currently licensed childhood vaccines and in response to the economic 
pressures that were threatening the integrity of childhood immunization programs.  
The litigation costs associated with claims of damage from vaccines had forced several 
companies to end their vaccine research and development programs as well as to stop 
producing already licensed vaccines.148  The development of this scheme was also 
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prompted by the idea that those who suffer the adverse consequences of a vaccination 
program designed for the public benefit should not bear the loss alone.149   
 
The National Vaccine Injury Compensation Program (“NVICP”) is a federal no-fault 
plan which was originally designed to provide compensation for injuries arising from 
vaccines recommended by the Centers of Disease Control and Prevention for routine 
administration to children.150  The NVICP has recently been expanded to cover the 
smallpox vaccine and the trivalent influenza vaccine, including injuries to adults from 
these vaccines.151  Although the scheme is narrower than Quebec’s plan in that it is 
mostly restricted to children, it is more broad with respect to compensable injuries in 
that it covers all injuries, illnesses, and death that arise from a vaccination.152 
 
To be eligible for compensation, the effects of any injury must have continued for at 
least six months and, until very recently, at least $1000 in non-reimbursable medical 
costs must have been incurred.153  Further, a claim must be made within 36 months of 
the appearance of the claimant’s first symptoms.  The program has somewhat reduced 
the causation problem by using a “Table of Injuries” that specifies known adverse 
reactions associated with specific vaccines within a given time period.154  If the 
claimant’s injury is recognized in the Table within a prescribed amount of time, the 
presumption of causation is in the complainant’s favour.  The government may attempt 
to rebut this presumption by presenting evidence of a definitive alternative cause such 
as an infection or trauma.155  If the claimant’s injury is not found in the Table, or it did 
not arise within the prescribed time period, he or she may independently of the Table 
prove that the injury is vaccine-related.156   
 
The amount of compensation payable to a claimant is assessed on tort principles.  There 
are certain limitations in respect to certain heads of damage.  Claims for pain and 
suffering are limited to $250 000.  Funding for the program comes from an excise tax 
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paid by the manufacturer on the sale of every dose of childhood vaccine.  The tax is 
accumulated in the Vaccine Injury Compensation Fund.  As of August 5, 1997, the 
excise tax has been set at a flat rate of 75¢ per dose of vaccine.157  In roughly a 15-year 
period since its inception, there have been 5,335 claims and 1,390 successful claimants, 
thus resulting in a success rate of approximately 25%.  In 2003, the average award was 
$1 427 169.158 
 
Tort actions for vaccine injuries have been severely limited by the NVICP.  No tort 
litigation may be commenced against a manufacturer or a health care provider in 
respect of a vaccine injury until a claim has been pursued through the NVICP and the 
claimant has either refused the offered compensation or has failed to establish his or her 
case.159 
 
Overall, the compensation scheme in the U.S. for vaccine-related injuries represents a 
more complex scheme but one that is arguably more comprehensive than the scheme in 
Quebec.   
 
X. RECOMMENDATIONS FOR CANADA 
 
As stated above, the only province in Canada which currently has a compensation plan 
in place is Quebec.  The Law Reform Commissions of Saskatchewan and Manitoba have 
considered implementing such a plan, but as of yet, none are in place.  Drawing from 
the experience in other jurisdictions will be useful in developing a comprehensive 
vaccine-related injury compensation scheme throughout the rest of Canada.  In general, 
a no-fault vaccine compensation program should include the following elements: (1) the 
vaccines to be covered, (2) the compensable injuries, (3) the kinds of compensation, (4) 
the administrative mechanisms, and, (5) the relationship with existing compensation 
programs including civil legal avenues and social programs.160  The following is a 
discussion of some of the suggestions for implementing a no-fault scheme in the rest of 
Canada. 
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1. Vaccines Covered 
As in Quebec, the plan should cover all children who are immunized as part of a 
routine immunization program as well as adults who are injured from vaccination.161   
Although the circumstances surrounding vaccines given to children might justify giving 
them priority over adults, namely their age, vulnerability, dependence on substitute 
decision-makers, the social pressures on vaccinating children, and the importance of 
childhood immunization,162 the present situation in Canada regarding the crisis 
surrounding the H1N1 vaccine demands that adults be included in any compensation 
plan.  When Canada faces a pandemic, it is essential to encourage all members of 
society to be vaccinated in order to foster herd immunity.  By restricting compensation 
to children if a vaccine injury occurs, there may not be sufficient incentives for adults to 
risk receiving a vaccine.  Therefore, it is important to also provide compensation to 
adults who may be injured in an act that serves to benefit society on the whole.  
 
It is clear that some types of vaccinations are sought primarily out of self-interest and 
confer substantial benefit on the recipient of the vaccine.  Vaccinations obtained in 
advance of travel to regions where infectious diseases are endemic are one such 
example.163  One possible compensation policy, then, would be to offer compensation 
where the circumstances of the injured person's vaccination fit the description of a 
collective-action problem: where there is an outcome that makes all members of a group 
better off, but which they cannot achieve because they cannot agree on how to share the 
costs or cannot enforce all members to share the cost.164  In the context of vaccination 
programs, the relevant public good is herd immunity against the disease.  Therefore, 
compensation should be available when the person accepted vaccination, 
notwithstanding a personal risk/benefit calculation suggesting that he should refuse it, 
but not where vaccination was clearly in the person's self-interest.165 
 
2. Compensable Injuries 
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Compensable injuries should not be restricted to “grave and permanent mental or 
physical damage” as is covered under the Quebec plan.  Instead, the plan should cover 
any disability, illness, or death that was caused by vaccination.  A table of injuries, 
qualifications, and aids for interpretation, such as that which is used in the United 
States, would be an ideal mechanism to determine compensable injuries.  A table and 
other aids would list all of the compensable injuries and respective time frames for their 
occurrence for each vaccine approved for use in the province or territory.  This would 
function so as to alleviate the burden of proof on a claimant, to ensure consistency and 
predictability of claims, and to confine the scope of claims within a reasonable range of 
injuries.166  The table of injuries should be carefully designed in consultation with 
medical experts and manufacturers and after a careful review of the scientific 
evidence.167  The table should be reviewed and updated regularly to reflect scientific 
advancements.  If the development and continual update of a province-specific table 
would be beyond the financial and medical resources of that particular jurisdiction, 
then the United States’ table could be adopted by reference.168   
 
A presumption of causation should arise if an injury falls within the table.  The onus of 
proof would then shift to the government to show that there is another likely cause of 
the injury other than the vaccine.  If the injury does not fall within the scope of the table, 
then the claimant would have to prove on a balance of probabilities that the vaccine 
caused the injuries. 
 
Finally, a generous limitation period is warranted by possible medical uncertainty as to 
the cause of the death or injury.  Reasonable limitation periods are important to ensure 
that a claim is assessed at a time when the best evidence is most readily available.  The 
time limitation to bring the claim should commence no sooner than the date of 
diagnosis, or in the case of fatalities, the date of death.169   
 
3. Compensation 
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There are various possibilities for calculating compensation to claimants.  
Comprehensive awards may be calculated based on tort principles.  This would include 
future care and loss of income, as well as limited non-pecuniary damages.  This would 
be the most generous measure of compensation but it has some disadvantages, 
including the difficulty, time, and expense of personalized assessments as required in 
the tort process and its inconsistency with other no-fault schemes which do not use tort 
principles.170    
 
Instead, it may be more beneficial for other provinces to follow the model of Quebec.  
The assessment of benefits could be made in accordance with the rules of another 
provincial no-fault scheme if one is available.  This procedure would avoid the many 
administrative barriers that would arise in establishing a completely new system.   
Compensation would include income replacement, compensation for physical 
disability, future care costs, rehabilitation expenses and death benefits to family. 
 
4. Administrative Mechanisms 
In establishing an institution to administer the program, provinces could create a 
discrete administrative tribunal such as the United States’ Childhood Vaccination Injury 
Compensation Board with its own staff and procedures.  However, based on the 
number of claims brought in Quebec, it is unlikely that there would be a sufficient 
number of claims to warrant the expense of an independent institution.  Instead, other 
provinces should follow the lead of Quebec where compensation to vaccine-injured 
individuals can “piggy-back” on an already existing no-fault scheme if one is 
available.171 
 
The government department most suited to administer a vaccination injury 
compensation scheme is that of Health.  The Minister could appoint an employee who 
would handle vaccine injury claims and determine the eligibility of the claimants under 
the Act.  Those who have their claims rejected should be able to bring appeals to an 
independent administrative tribunal.172 
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The system could possibly be set up nationally or by each province and territory.  
Provinces have primary constitutional jurisdiction over compensation and the delivery 
of immunization is a provincial and territorial responsibility.173  However, Canada has a 
national health care system within which funding is a federal initiative under the 
Canada Health Act.174  Plus, the organization of physicians and other health care 
providers is set up nationally (C.M.P.A., CMA, etc.).  Although Canada would be well 
served by the implementation of a national plan, provincial/territorial plans specifically 
tailored to reflect differing circumstances and constitutional jurisdiction may be the best 
route.175 
 
Finally, funding options would also most likely have to follow the Quebec model.  A 
charge on each vaccine sold, as is levied through the United States’ system, would 
probably be impermissible as a user charge on health care under the Canada Health 
Act.176  The realistic option would be to make the cost of the scheme a charge on general 
tax revenues.  This option has the added advantage of spreading the cost in the widest 
manner throughout society, which, as a whole, receives the benefits of immunization 
programs.177   
 
5. The Relationship with Existing Compensation Programs 
To the extent that a claimant may be compensated through other programs, the scheme 
should be entitled to reimbursement.178  As well, there does not appear to be any 
pressing reason to remove a claimant’s ability to proceed through tort actions.  The 
scheme should not limit a claimant’s right to sue a manufacturer, physician, or any 
other defendant for negligence, lack of informed consent, or breach of a duty to warn.   
The history of tort litigation in the field of vaccines suggests that litigation in respect of 
vaccine injuries will be infrequent.179  If a tort action is successful, the monies received 
through the no-fault scheme should be reimbursed so as to avoid double compensation. 
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XI. IMPACT OF THE NEW H1N1 VACCINE 
 
Canada recently faced a crisis that it was unprepared to handle: the H1N1 pandemic.  
H1N1 is a new strain of influenza, and because humans have little to no natural 
immunity to this virus, it can cause serious and widespread illness.180  As of April 3, 
2010, 428 people had died in Canada from the H1N1 flu virus.181  Since the H1N1 flu 
virus first appeared in Canada in the spring of 2009, manufacturers scrambled to 
produce and deliver an effective vaccine.  Ottawa purchased 50.4 million doses of the 
vaccine from the manufacturer GlaxoSmithKline PLC, and as of late October 2009, the 
vaccine had been approved for rollout across Canada.182 
 
Despite the fact that H1N1 has been a particularly deadly form of influenza, targeting 
not only vulnerable populations, but healthy young people, many Canadians have 
expressed concern that the H1N1 vaccine is unsafe, and an unwillingness to receive the 
vaccine.  The most common complaint is that the vaccine has been newly formed and 
quickly distributed without the benefit of clinical trials.183  Public Health Agency of 
Canada officials acknowledged in July that that there would not be time for a swine flu 
vaccine to go through standard safety testing before immunizations began.184  Despite 
these concerns, Health Canada assured Canadians that the new vaccine was safe.  It was 
manufactured in the same way as the regular flu vaccine and was subject to the same 
scrutiny and regulatory oversight.  In order to be approved and sold in Canada, the 
benefits of the vaccine needed to outweigh the risks.185  Therefore, the system of 
approval in fact acknowledges that some persons may suffer adverse effects from the 
vaccine. 
 
The fears over the new vaccine are not entirely unfounded.  The last time there was an 
outbreak of swine flu in the U.S., more people were harmed by the vaccine than by the 
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actual flu.  In 1976, an outbreak of swine flu at the Fort Dix army base in New Jersey 
spawned a nationwide emergency vaccination program.  About 45 million Americans 
were vaccinated.  In the end, the deadly pandemic that officials feared never 
materialized.  Instead, thousands of Americans suffered side effects from the vaccine – 
including about 500 people who developed a paralyzing neurological disorder called 
Guillain-Barre Syndrome.  Many U.S. citizens believed that officials were trying to hide 
serious complications when they insisted the vaccine was safe.  More than 5,000 people 
sued the federal government for vaccine-related injuries, resulting in payouts totaling 
$73 million.186 
 
Furthermore, many Canadians are fearful of the adjuvants added to the new H1N1 
vaccine.  Adjuvants are sometimes added to vaccines to boost the immune system and 
to increase an individual’s response to a vaccine.  Unlike in the U.S., where no adjuvant 
is used in any H1N1 vaccines, Canada has approved the use of adjuvants even though 
they have not previously been approved for use with influenza vaccines in Canada.187   
Both Health Canada and WHO have declared that there are no significant safety 
concerns regarding the use of the adjuvanted vaccine.  Yet, the adjuvanted H1N1 flu 
vaccine is not recommended for everyone.  Only the unadjuvanted vaccine is 
recommended for pregnant women.  The reason cited for this is that there is no clinical 
data on the safety of the adjuvanted vaccine in this group.188  Although some Canadians 
on the front lines of health care have expressed concerns about taking the H1N1 vaccine 
until more is known about it and the adjuvant it contains, federal health officials have 
noted that “the risks from the vaccine are only theoretical while the risk of severe 
disease and even death from H1N1 are too real to ignore.”189 
 
As of late October, 2009, according to clinical trials and adverse event monitoring 
during deployment of vaccines in early introducer countries, there were no indications 
that unusual adverse events had been observed after H1N1 immunization.  However, 
WHO reports that the need for continued vigilance and regular evaluation by health 
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authorities is ongoing.190  In Canada, as of November 7, 2009, out of 6.6 million H1N1 
vaccinations given, there were 36 reported serious adverse reactions to the vaccine and 
one suspected death.  An 80-year-old man from Quebec died after being vaccinated 
against the H1N1 flu, although officials say that it is too soon to determine whether the 
vaccine played a role in the death of the man who had underlying health issues.191   
 
Recently, the federal government announced that it had agreed to shield drug 
companies from lawsuits over the H1N1 pandemic vaccine.  Canadians who suffer 
harmful effects from the new vaccine can still take the vaccine maker to court, but the 
federal government will be responsible for any damages.  The chief public health 
officer, Dr. David Butler-Jones, stated that “we’re not obviously anticipating problems 
with it, but having indemnification for a vaccine is important.”192  The provision does 
not apply, however, in the case of malpractice, where the manufacturer will still be 
liable for any negligence during the manufacturing process. 
 
Although the government has taken the steps to protect the H1N1 vaccine 
manufacturer, with the exception of Quebec, provinces and territories have not yet 
made any plans to compensate people who have been injured after conceptually buying 
into the immunization program for the benefit of all Canadians.  A leading public 
health expert, Kumanan Wilson, has been calling on Canada to create a no-fault 
compensation program for people who may be harmed by a swine flu vaccine that 
millions of Canadians are being urged by the government to receive.  In an interview 
with Canwest News Service, he stated:  
I’m not saying that we shouldn’t roll out this vaccine.  I don’t know how 
confident we will be in its efficacy and safety at the outset, but I don’t 
think we’ll have any choice but to roll it out, because, at this point, the 
only way to control the spread is going to be a vaccine.  But, there are 
going to be concerns about people not wanting to take the vaccine, health-
care workers in particular.  We have been arguing that it needs to be 
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complemented with a no-fault compensation program, just like in 1976, 
and we need to develop systems to pick up these adverse events.193  
 
Currently, those who are harmed by vaccines are treated as collateral damage in the 
war against vaccine-preventable illness.  The only just, ethical, and sensible thing to do 
is for Canada to compensate people who have been exposed to a potential harm while 
undergoing an intervention that is in the greater public good.  In the words of Judge 
Sanderson from Morgan v. Metropolitan Toronto (Municipality), it is necessary “for the 
sake of the health of citizens and fairness to individuals.”194 
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